- Home
- ROIV vs SQM Comparison
ROIV vs SQM Comparison
Compare ROIV & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | SQM |
|---|---|---|
| Founded | 2014 | 1968 |
| Country | United Kingdom | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 22.0B |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ROIV | SQM |
|---|---|---|
| Price | $28.02 | $92.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $28.94 | ★ $68.80 |
| AVG Volume (30 Days) | ★ 4.4M | 1.3M |
| Earning Date | 05-28-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $744.61 | $7.83 |
| P/E Ratio | ★ N/A | $39.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.58 | $29.36 |
| 52 Week High | $30.33 | $95.46 |
Technical Indicators
Market Signals| Indicator | ROIV | SQM |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 61.94 |
| Support Level | $27.00 | $68.06 |
| Resistance Level | $30.26 | $95.46 |
| Average True Range (ATR) | 0.90 | 3.45 |
| MACD | -0.14 | 0.12 |
| Stochastic Oscillator | 31.41 | 73.78 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.